Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2014

Open Access 01-12-2014 | Research article

Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan

Authors: Muhammad Yakoob Ahmedani, Syed Faraz Danish Alvi, Muhammad Saif Ul haque, Asher Fawwad, Abdul Basit

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2014

Login to get access

Abstract

Background

To observe the outcome of implementation of Ramadan-specific diabetes management recommendations in fasting individuals with diabetes through health care providers.

Methods

This multi-centered prospective study was conducted at nine diabetes specialist centers in four provinces of Pakistan. The study was carried out in two phases; pre-Ramadan recruitment interview (visit A) and post-Ramadan follow up interview (visit B) of the same patients. Pre-Ramadan individual counseling was given and educational material provided to each patient by health care providers during visit A.

Results

Out of 388 patients with diabetes, blood glucose level was checked by all patients with type 1 and 71.43% patients with type 2 diabetes when they developed hypoglycemic symptoms during Ramadan. Of patients with type 1 and type 2 diabetes, 33.33% and 48% discontinued their fast when they felt hypoglycemic symptoms, respectively. None of the patient with type 1, while 18.87% patients with type 2 diabetes discontinued fast on the development of hyperglycemic symptoms. Drug dosage and timing were altered in 80% patients with type 1 and 90.5% patients with type 2 diabetes during Ramadan. Majority of the patients with type 2 diabetes changed from moderate/severe levels of physical activity before Ramadan to light physical activity during Ramadan (p<0.000). None of the patients required hospitalization when they developed symptomatic hypoglycemia or hyperglycemia and none developed diabetic ketoacidosis and hyperglycemic hyperosmolar state during Ramadan.

Conclusion

We observed that it is practicable to implement Ramadan-specific diabetes management recommendations through health care providers.
Literature
1.
go back to reference Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A, EPIDIAR study group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422⁄2001(EPIDIAR) study. Diabetes Care 2004, 27: 2306–2311. 10.2337/diacare.27.10.2306CrossRefPubMed Salti I, Benard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, Jabbar A, EPIDIAR study group: A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422⁄2001(EPIDIAR) study. Diabetes Care 2004, 27: 2306–2311. 10.2337/diacare.27.10.2306CrossRefPubMed
2.
go back to reference Elhadd TA, Al-Amoudi AA: Recommendations for management of diabetes during Ramadan. Diabetes Care 2006, 29: 744–745. 10.2337/diacare.29.03.06.dc05-2102CrossRefPubMed Elhadd TA, Al-Amoudi AA: Recommendations for management of diabetes during Ramadan. Diabetes Care 2006, 29: 744–745. 10.2337/diacare.29.03.06.dc05-2102CrossRefPubMed
3.
go back to reference Bravis V, Hui E, Salih S, Mehar S, Hassanein M, Devendra D: Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med 2010, 27: 327–331. 10.1111/j.1464-5491.2010.02948.xCrossRefPubMed Bravis V, Hui E, Salih S, Mehar S, Hassanein M, Devendra D: Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med 2010, 27: 327–331. 10.1111/j.1464-5491.2010.02948.xCrossRefPubMed
4.
go back to reference Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A, Nakhi A, Tayeb K, Thomas A: Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010, 33: 1895–1902. 10.2337/dc10-0896CrossRefPubMedPubMedCentral Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A, Nakhi A, Tayeb K, Thomas A: Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010, 33: 1895–1902. 10.2337/dc10-0896CrossRefPubMedPubMedCentral
5.
go back to reference Benaji B, Mounib N, Roky R, Aadil N, Houti IE, Moussamih S, Maliki S, Gressier B, El Ghomari H: Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract 2006, 73: 117–125. 10.1016/j.diabres.2005.10.028CrossRefPubMed Benaji B, Mounib N, Roky R, Aadil N, Houti IE, Moussamih S, Maliki S, Gressier B, El Ghomari H: Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract 2006, 73: 117–125. 10.1016/j.diabres.2005.10.028CrossRefPubMed
7.
go back to reference Mahmoud AI: Managing diabetes during Ramadan. Diabetes Voice 2007, 52: 19–22. Mahmoud AI: Managing diabetes during Ramadan. Diabetes Voice 2007, 52: 19–22.
8.
go back to reference Ahmedani MY, Haque MS, Basit A, Fawwad A, Alvi SF: Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabet Med 2012, 29: 709–715. 10.1111/j.1464-5491.2011.03563.xCrossRefPubMed Ahmedani MY, Haque MS, Basit A, Fawwad A, Alvi SF: Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabet Med 2012, 29: 709–715. 10.1111/j.1464-5491.2011.03563.xCrossRefPubMed
9.
go back to reference Akbani MF, Saleem M, Gadit WU, Ahmed M, Basit A, Malik RA: Fasting and feasting safely during Ramadan in the patient with diabetes. Pract Diab Int 2005, 22: 100–104. 10.1002/pdi.767CrossRef Akbani MF, Saleem M, Gadit WU, Ahmed M, Basit A, Malik RA: Fasting and feasting safely during Ramadan in the patient with diabetes. Pract Diab Int 2005, 22: 100–104. 10.1002/pdi.767CrossRef
10.
go back to reference Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, Ismail-Beigi F, El-Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi A, Al-Rubean K: Recommendations for management of diabetes during Ramadan. Diabetes Care 2005, 28: 2305–2311. 10.2337/diacare.28.9.2305CrossRefPubMed Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, Ismail-Beigi F, El-Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi A, Al-Rubean K: Recommendations for management of diabetes during Ramadan. Diabetes Care 2005, 28: 2305–2311. 10.2337/diacare.28.9.2305CrossRefPubMed
11.
go back to reference Hassanein MM: Diabetes and Ramadan-How to achieve a safer fast for Muslims with diabetes. Br J Diabetes Vasc Dis 2010, 10: 246–250. 10.1177/1474651410380150CrossRef Hassanein MM: Diabetes and Ramadan-How to achieve a safer fast for Muslims with diabetes. Br J Diabetes Vasc Dis 2010, 10: 246–250. 10.1177/1474651410380150CrossRef
12.
go back to reference Ahmedani MY, Riaz M, Fawwad A, Hydrie MZI, Hakeem R, Basit A: Glycaemic trend during Ramadan in fasting diabetic subjects – a study from Pakistan. Pak J Biol Sci 2008, 11: 2044–2047. 10.3923/pjbs.2008.2044.2047CrossRef Ahmedani MY, Riaz M, Fawwad A, Hydrie MZI, Hakeem R, Basit A: Glycaemic trend during Ramadan in fasting diabetic subjects – a study from Pakistan. Pak J Biol Sci 2008, 11: 2044–2047. 10.3923/pjbs.2008.2044.2047CrossRef
13.
go back to reference Khatib FA, Shafagoj YA: Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Saudi Med J 2004, 25: 1858–1863.PubMed Khatib FA, Shafagoj YA: Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Saudi Med J 2004, 25: 1858–1863.PubMed
14.
go back to reference Mafauzy M, Mohammed WB, Anum MY, Zulkifli A, Ruhani AH: A study of fasting diabetic patients during the month of Ramadan. Med J Malaysia 1990, 45: 14–17.PubMed Mafauzy M, Mohammed WB, Anum MY, Zulkifli A, Ruhani AH: A study of fasting diabetic patients during the month of Ramadan. Med J Malaysia 1990, 45: 14–17.PubMed
15.
go back to reference Sari R, Balci MK, Akbas SH, Avci B: The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004, 30: 169–177. 10.1081/ERC-200027375CrossRefPubMed Sari R, Balci MK, Akbas SH, Avci B: The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res 2004, 30: 169–177. 10.1081/ERC-200027375CrossRefPubMed
16.
go back to reference Laajam MA: Ramadan fasting and non-Ramadan fasting serum fasting serum glucose in insulin-dependent diabetes: Effect on metabolic healthy adult’s. Med J Malaysia 2003, 48: 678–680. Laajam MA: Ramadan fasting and non-Ramadan fasting serum fasting serum glucose in insulin-dependent diabetes: Effect on metabolic healthy adult’s. Med J Malaysia 2003, 48: 678–680.
17.
go back to reference Chong TW: Diabetes Mellitus and fasting during Ramadan. The Singapore Family Physician 2011, 37: 52–59. Chong TW: Diabetes Mellitus and fasting during Ramadan. The Singapore Family Physician 2011, 37: 52–59.
Metadata
Title
Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan
Authors
Muhammad Yakoob Ahmedani
Syed Faraz Danish Alvi
Muhammad Saif Ul haque
Asher Fawwad
Abdul Basit
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2014
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/2251-6581-13-37

Other articles of this Issue 1/2014

Journal of Diabetes & Metabolic Disorders 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine